Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1993 1
1994 1
1995 2
1996 1
2000 1
2001 2
2002 1
2003 5
2004 5
2005 3
2006 5
2007 1
2008 4
2009 7
2010 7
2011 8
2012 7
2013 4
2014 2
2015 2
2016 14
2017 8
2018 6
2019 7
2020 8
2021 7
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
The challenge of the new tuberculosis drugs.
Tiberi S, Buchanan R, Caminero JA, Centis R, Arbex MA, Salazar M, Potter J, Migliori GB. Tiberi S, et al. Among authors: caminero ja. Presse Med. 2017 Mar;46(2 Pt 2):e41-e51. doi: 10.1016/j.lpm.2017.01.016. Epub 2017 Feb 28. Presse Med. 2017. PMID: 28256383 Review. French.
Multidrug-resistant tuberculosis.
Caminero JA, García-Basteiro AL, Rendon A. Caminero JA, et al. Lancet. 2019 Jul 27;394(10195):298. doi: 10.1016/S0140-6736(19)30696-8. Lancet. 2019. PMID: 31354137 No abstract available.
Management of Multidrug-Resistant Tuberculosis.
Daley CL, Caminero JA. Daley CL, et al. Among authors: caminero ja. Semin Respir Crit Care Med. 2018 Jun;39(3):310-324. doi: 10.1055/s-0038-1661383. Epub 2018 Aug 2. Semin Respir Crit Care Med. 2018. PMID: 30071546 Review.
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Global Tuberculosis Network and TB/COVID-19 Global Study Group; Casco N, Jorge AL, Palmero DJ, Alffenaar JW, Fox GJ, Ezz W, Cho JG, Denholm J, Skrahina A, Solodovnikova V, Arbex MA, Alves T, Rabahi MF, Pereira GR, Sales R, Silva DR, Saffie MM, Salinas NE, Miranda RC, Cisterna C, Concha C, Fernandez I, Villalón C, Vera CG, Tapia PG, Cancino V, Carbonell M, Cruz A, Muñoz E, Muñoz C, Navarro I, Pizarro R, Cristina Sánchez GP, Vergara Riquelme MS, Vilca E, Soto A, Flores X, Garavagno A, Bahamondes MH, Merino LM, Pradenas AM, Revillot ME, Rodriguez P, Salinas AS, Taiba C, Valdés JF, Subiabre JN, Ortega C, Palma S, Castillo PP, Pinto M, Bidegain FR, Venegas M, Yucra E, Li Y, Cruz A, Guelvez B, Victoria Plaza R, Tello Hoyos KY, Cardoso-Landivar J, Van Den Boom M, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Gupta N, Ish P, Mishra G, Patel JM, Singla R, Udwadia ZF, Alladio F, Angeli F, Calcagno A, Centis R, Codecasa LR, De Lauretis A, Esposito SMR, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Matteelli A, Migliori GB, Motta I, Palmieri F, Pontali E, Prestileo T, Riccardi N, Sad… See abstract for full author list ➔ Global Tuberculosis Network and TB/COVID-19 Global Study Group, et al. Among authors: caminero ja. Eur Respir J. 2023 Nov 29;62(5):2300925. doi: 10.1183/13993003.00925-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37827576 Free PMC article.
Tuberculosis in Spain: An opinion paper.
Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Santiago B, Caminero JA, Barros C, García de Viedma D, Martín C, Bouza E. Moreno Guillén S, et al. Among authors: caminero ja. Rev Esp Quimioter. 2023 Dec;36(6):562-583. doi: 10.37201/req/115.2023. Epub 2023 Nov 2. Rev Esp Quimioter. 2023. PMID: 37922367 Free PMC article. Review.
The economic burden of multidrug-resistant tuberculosis.
Caminero JA, Scardigli A. Caminero JA, et al. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):831-832. doi: 10.5588/ijtld.18.0408. Int J Tuberc Lung Dis. 2018. PMID: 29991388 No abstract available.
Curving Tuberculosis: Current Trends and Future Needs.
Rojano B, Caminero JA, Hayek M. Rojano B, et al. Among authors: caminero ja. Ann Glob Health. 2019 Jan 22;85(1):5. doi: 10.5334/aogh.2415. Ann Glob Health. 2019. PMID: 30741506 Free PMC article. Review.
Tuberculosis: are we making it incurable?
Caminero JA, Matteelli A, Loddenkemper R. Caminero JA, et al. Eur Respir J. 2013 Jul;42(1):5-8. doi: 10.1183/09031936.00206712. Eur Respir J. 2013. PMID: 23813308 Free article. No abstract available.
Clinical standards for drug-susceptible pulmonary TB.
Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB. Akkerman OW, et al. Among authors: caminero ja. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):592-604. doi: 10.5588/ijtld.22.0228. Int J Tuberc Lung Dis. 2022. PMID: 35768923 Free PMC article.
The Historical Need for a National Tuberculosis Program for Spain.
Caylà JA, Caminero JA. Caylà JA, et al. Among authors: caminero ja. Arch Bronconeumol (Engl Ed). 2018 Dec;54(12):603-604. doi: 10.1016/j.arbres.2018.06.013. Epub 2018 Jul 23. Arch Bronconeumol (Engl Ed). 2018. PMID: 30049559 English, Spanish. No abstract available.
120 results